Drug intelligence / Profile preview

GMM-2

Development stage
Unknown
Lead developer
A-Citius
Modality
Small Molecules
Administration
Oral
01

Overview

GMM-2 is a combination pharmaceutical drug indicated for the treatment of type 2 diabetes mellitus. It comprises two active ingredients: Glimepiride and Metformin. Glimepiride, a sulfonylurea, acts by stimulating the beta cells in the pancreas to produce and release more insulin, thereby lowering blood sugar levels. Metformin, a biguanide, works through multiple mechanisms, including reducing glucose production by the liver, delaying glucose absorption from the intestines, and increasing the sensitivity of muscle cells to insulin, which allows for more effective glucose uptake from the blood. This dual-action approach aims to improve glycemic control in adult patients whose blood sugar levels are not adequately managed by diet and exercise alone.

Brand names
Gmm-2 TabletGmm2 TabletGmm 2 TabletGMM 2 Tablet PRGMM2 Tablet PRGMM-2 Tablet PR
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on GMM-2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GMM-2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call